Turbine Establishes Research Collaboration with Ono Pharmaceutical to Identify and Validate Novel Oncology Targets
Turbine Appoints Pharma Industry Veteran Bob Silverman as Chief Business Officer
Hero
Our Approach
Simulations capture patient biology where experiments fail
Platform
Engineering a way to understand biology
Pipeline
A single platform to rationalize the entire R&D process
Meet Us
Building deep tech for deep biology
Notification
Join our mission
Read about us
Hero
Our Approach
Platform
Pipeline
Meet Us
Notification
Join our mission
Read about us
KLAUS HOEFLICH
ex Senior Vice President of Biology at Blueprint Medicines
All rights reserved ©2023 Turbine Ltd. |
Privacy Policy
|
Created by Art&Board Studio
close
